The magic of technical analysis and fundamental analysis (TA&FA) once again proves itself as the Sector Rotation Strategy for Swing Trader generates an impressive 18.41% return for CHRD. This strategy involves moving investments between different sectors in response to market cycle changes and macroeconomic trends, and it seems to be paying off for CHRD investors.
CHRD has displayed an encouraging bullish trend, with the price showing a promising +5.50% three-day advance. Historically, out of 306 similar instances, the price rose further in 258 cases within the subsequent month. This represents a robust 84% probability of an upward price trajectory continuation, reflecting strong confidence in the strategy's future performance.
Another significant indication of CHRD's positive performance is the recent movement of the Aroon Indicator, which entered an uptrend today. The Aroon Indicator is a popular tool among traders to determine whether a stock is trending or not, and in what magnitude. It is designed to reveal the start of a new trend, and its strength, and can also anticipate changes in a trend.
With respect to CHRD, the Aroon Indicator's entry into an uptrend has historically resulted in a price increase in 185 out of 249 cases within the following month. This solidifies an impressive 74% likelihood of an ongoing uptrend.
The use of technical and fundamental analysis within the Sector Rotation Strategy for Swing Trading has reaped remarkable benefits for CHRD. Both the three-day advance and Aroon Indicator's movement into an uptrend represent strong indicators of continued positive performance. With such robust potential, CHRD provides an excellent example of how swing traders can leverage sector rotation to their advantage, harnessing the power of market cycles for impressive returns.
CHRD saw its Momentum Indicator move below the 0 level on September 15, 2023. This is an indication that the stock could be shifting in to a new downward move. Traders may want to consider selling the stock or exploring put options. Tickeron's A.I.dvisor looked at 87 similar instances where the indicator turned negative. In of the 87 cases, the stock moved further down in the following days. The odds of a decline are at .
The 10-day RSI Indicator for CHRD moved out of overbought territory on September 05, 2023. This could be a bearish sign for the stock. Traders may want to consider selling the stock or buying put options. Tickeron's A.I.dvisor looked at 38 similar instances where the indicator moved out of overbought territory. In of the 38 cases, the stock moved lower in the following days. This puts the odds of a move lower at .
The Moving Average Convergence Divergence Histogram (MACD) for CHRD turned negative on September 11, 2023. This could be a sign that the stock is set to turn lower in the coming weeks. Traders may want to sell the stock or buy put options. Tickeron's A.I.dvisor looked at 45 similar instances when the indicator turned negative. In of the 45 cases the stock turned lower in the days that followed. This puts the odds of success at .
CHRD moved below its 50-day moving average on September 19, 2023 date and that indicates a change from an upward trend to a downward trend.
Following a 3-day decline, the stock is projected to fall further. Considering past instances where CHRD declined for three days, the price rose further in of 62 cases within the following month. The odds of a continued downward trend are .
CHRD broke above its upper Bollinger Band on August 31, 2023. This could be a sign that the stock is set to drop as the stock moves back below the upper band and toward the middle band. You may want to consider selling the stock or exploring put options.
The Stochastic Oscillator shows that the ticker has stayed in the oversold zone for 3 days. The price of this ticker is presumed to bounce back soon, since the longer the ticker stays in the oversold zone, the more promptly an upward trend is expected.
Following a 3-day Advance, the price is estimated to grow further. Considering data from situations where CHRD advanced for three days, in of 314 cases, the price rose further within the following month. The odds of a continued upward trend are .
The Aroon Indicator entered an Uptrend today. In of 258 cases where CHRD Aroon's Indicator entered an Uptrend, the price rose further within the following month. The odds of a continued Uptrend are .
The Tickeron Profit vs. Risk Rating rating for this company is (best 1 - 100 worst), indicating low risk on high returns. The average Profit vs. Risk Rating rating for the industry is 77, placing this stock better than average.
The Tickeron Valuation Rating of (best 1 - 100 worst) indicates that the company is seriously undervalued in the industry. This rating compares market capitalization estimated by our proprietary formula with the current market capitalization. This rating is based on the following metrics, as compared to industry averages: P/B Ratio (1.338) is normal, around the industry mean (6.231). P/E Ratio (3.052) is within average values for comparable stocks, (16.603). Projected Growth (PEG Ratio) (0.000) is also within normal values, averaging (2.541). Dividend Yield (0.084) settles around the average of (0.124) among similar stocks. P/S Ratio (1.679) is also within normal values, averaging (120.481).
The Tickeron SMR rating for this company is (best 1 - 100 worst), indicating very strong sales and a profitable business model. SMR (Sales, Margin, Return on Equity) rating is based on comparative analysis of weighted Sales, Income Margin and Return on Equity values compared against S&P 500 index constituents. The weighted SMR value is a proprietary formula developed by Tickeron and represents an overall profitability measure for a stock.
The Tickeron Price Growth Rating for this company is (best 1 - 100 worst), indicating steady price growth. CHRD’s price grows at a higher rate over the last 12 months as compared to S&P 500 index constituents.
The Tickeron PE Growth Rating for this company is (best 1 - 100 worst), pointing to worse than average earnings growth. The PE Growth rating is based on a comparative analysis of stock PE ratio increase over the last 12 months compared against S&P 500 index constituents.
The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows
a company which engages in the acquisition and development of oil & natural gas resources
|ETFs / NAME||Price $||Chg $||Chg %|
|iShares 1-3 Year Treasury Bond ETF|
|BondBloxx B Rated USD Hi Yld Corp Bd ETF|
|PRINCIPAL REAL ESTATE Income FUND|
|Dimensional International Small Cap ETF|
|Invesco Trust for Investment Grade New York Municipals|
A.I.dvisor indicates that over the last year, CHRD has been closely correlated with MGY. These tickers have moved in lockstep 84% of the time. This A.I.-generated data suggests there is a high statistical probability that if CHRD jumps, then MGY could also see price increases.